Skip to content

Role of Routine Nasogastric Decompression After Subtotal Gastrectomy

Role of Routine Nasogastric Decompression After Subtotal Gastrectomy

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00164918
Enrollment
90
Registered
2005-09-14
Start date
2004-09-30
Completion date
Unknown
Last updated
2005-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Stomach

Brief summary

The aim of the study is to evaluate whether subtotal gastrectomy without post-operative nasogastric decompression is better in terms of early post-operative bowel function and chest complication.

Detailed description

Nasogastric decompression is an intra-operative routine in most of the time to facilitate exposure of operative field during elective subtotal gastrectomy, but whether it should be retained post-operatively is controversial. Nasogastric decompression helps to drain the gastric remnant in case there is edema around the gastrojejunostomy, ileus and delayed gastric emptying, which can theoretically relieve nausea and abdominal distension. Besides, it may help decrease diaphragmatic splintage and hence decrease chance of chest infection if ileus occurs. However, nasogastric intubation could cause patient discomfort; also it has been shown that it would cause gastroesophageal reflux which may be associated with chest complication. There have been studies showing that routine post-operative nasogastric decompression is not necessary for gastrectomy in general, but the role in subtotal gastrectomy for stomach cancer is not well defined.

Interventions

DEVICEnasogastric tube

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Weeks to No maximum
Healthy volunteers
No

Inclusion criteria

All patients suffering from carcinoma of stomach, decided for operation * subtotal, D1/D2 dissection * palliative resection

Exclusion criteria

* actively bleeding tumor * perforation of tumor * patient present with gastric outlet obstruction * combine organ excision * known diabetes with nephropathy

Design outcomes

Primary

MeasureTime frame
Bowel function and related symptoms early post-op

Countries

China

Contacts

Primary ContactEnders K. W. Ng, MD
endersng@surgery.cuhk.edu.hk85226322627
Backup ContactMan Yee Yung, BN
myyung@surgery.cuhk.edu.hk85226322956

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026